CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on July 30, 2008 under Uncategorized | Be the First to Comment
A PDE Model for Imatinib-Treated Chronic Myelogenous Leukemia.
Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.
Posted by rob on July 25, 2008 under Uncategorized | Be the First to Comment
Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty.
Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants.
Posted by rob on July 18, 2008 under Uncategorized | Be the First to Comment
Transformation by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type Requires the Tyrosine Residues 589 and 591.
Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation.
Posted by rob on July 16, 2008 under Uncategorized | Be the First to Comment
Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.
The role of beta-catenin in chronic myeloproliferative disorders.
Posted by rob on July 9, 2008 under Uncategorized | Be the First to Comment
Anti-Bcl2 therapy in chronic myelogenous leukemia.
The Jeremiah Metzger Lecture: intelligent design of cancer therapy: trials and tribulations.